The tariffs, which take effect Feb. 10, are most likely to hurt communities that voted for Trump, according to a study

(Reuters) - President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new tariffs on Chinese imports, as they join big pharma lobbyists who have said such trade barriers will cause shortages of medicines and higher prices in the United States.

U.S. agreements with Canada and Mexico stopped tariffs before they were to enter into effect, but the trade war between the world’s top two economies is continuing.